P

PRTA

PRTA

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
29%Bearish
Buy/Sell Ratio100% buys
BearishBullish
PRTA Live QuoteReal-time
$8.40
+$0.37(+4.61%)1M
Day Range$8.17 – $8.49
Open$8.36
Previous Close$8.35
Volume567.0K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$428.77M
P/E Ratio (TTM)24.5
Forward P/E33.9
EPS (TTM)$-0.45
Price to Book1.6
Dividend Yield0.65%
Beta (Volatility)-0.21
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $8.40 (17%)
Low: $7.70High: $11.80
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$21.40-85.7% upside

Insider Buys

5

$5.12M

Insider Sales

0

$0

Total Volume

$5.12M

17 transactions

Net Activity

+$5.12M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
75CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •High accumulation: total purchase value exceeds $1M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys12 sells

$773.99B total

S
2

Scully William P

10%

5 buys0 sells

$5.12M total

Trading History
PRTA insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 17, 2026

3 days ago

Scully William P

10%

10% Owner
Buy50.0K$8.09$405K

Nov 9, 2026

1 weeks ago

Scully William P

10%

10% Owner
Buy140.0K$8.53$1.19M

Oct 22, 2026

4 weeks ago

Scully William P

10%

10% Owner
Buy150.0K$8.15$1.22M

Sep 29, 2026

1 months ago

Scully William P

10%

10% Owner
Buy162.0K$8.68$1.41M

Sep 28, 2026

1 months ago

Scully William P

10%

10% Owner
Buy103.5K$8.60$890K

Sep 18, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.06M$100000.00$106.25B

Sep 2, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell962.5K$27000.00$25.99B

Aug 20, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell935.5K$50000.00$46.77B

Aug 7, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell925.5K$37500.00$34.71B

Jul 29, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell55.8K$-7662.00$0

Jun 16, 2026

5 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell888.0K$20000.00$17.76B

Jun 11, 2026

5 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.19M$125000.00$149.13B

Jun 4, 2026

5 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.07M$50000.00$53.40B

Jun 2, 2026

5 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.02M$50000.00$50.90B

May 22, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell968.0K$100000.00$96.80B

May 2, 2025

18 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell5.30M$-6279684.00$0

Dec 18, 2024

23 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell926.9K$207436.00$192.28B
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
PRTA Buy Conviction100%
Industry Rank#305 of 569
Volume Contribution0.0%
Total Industry Activity$16.53B

PRTA has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. PRTA ranks #305 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for PRTA

Over the last 90 days, corporate insiders at PRTA (PRTA) engaged in a total of 17 transactions reported via SEC Form 4 filings. Among these, 5 were open-market purchases and 0 were sales. The total volume of insider trading reached $5.12M.

The net insider activity for PRTA shows a net buying bias of $5.12M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 926.9K shares valued at $192.28B on Dec 18, 2024.

Live Market News & Developments
Aggregated real-time headlines for PRTA (PRTA)
6 updates

Prothena (PRTA) 10% owner Scully bought 50,000 shares for $405K at $8.09

Quantisnow14h ago

CRMD vs. PRTA: Which Stock Should Value Investors Buy Now?

Yahoo Finance43d ago

PRTA News | PROTHENA CORP PLC (NASDAQ:PRTA)

ChartMill16d ago

PRTA - Prothena Corp Plc Stock Price and Quote

Finviz177d ago

After buying shares in Prothena (PRTA), William P. Scully holds more than 1 million shares directly.

Stock TitanYesterday

PRTA Stock Rises Nearly 11% in Six Months: What's Driving It?

TradingView134d ago

FAQs About PRTA Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for PRTA.

Based on SEC Form 4 disclosures, the Insider Confidence Score for PRTA is currently 75/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 5 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for PRTA is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.